BALLARINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.498
EU - Europa 4.013
AS - Asia 1.467
OC - Oceania 21
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
Totale 11.038
Nazione #
US - Stati Uniti d'America 5.405
IT - Italia 1.042
DE - Germania 998
CN - Cina 615
SE - Svezia 504
IE - Irlanda 403
SG - Singapore 364
RU - Federazione Russa 291
GB - Regno Unito 200
UA - Ucraina 190
HK - Hong Kong 134
AT - Austria 106
VN - Vietnam 103
CA - Canada 93
DK - Danimarca 74
FI - Finlandia 64
JP - Giappone 52
KR - Corea 50
IN - India 47
FR - Francia 46
TR - Turchia 35
BE - Belgio 30
ID - Indonesia 22
AU - Australia 18
PL - Polonia 17
IR - Iran 12
EU - Europa 10
MY - Malesia 10
NL - Olanda 10
EG - Egitto 9
TW - Taiwan 9
BR - Brasile 8
RO - Romania 8
BG - Bulgaria 7
ES - Italia 7
CZ - Repubblica Ceca 5
TN - Tunisia 5
KW - Kuwait 4
CH - Svizzera 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
LT - Lituania 2
NG - Nigeria 2
RS - Serbia 2
SC - Seychelles 2
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
IQ - Iraq 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 11.038
Città #
Ann Arbor 1.945
Frankfurt am Main 766
Milan 424
Chandler 406
Dublin 390
Wilmington 335
Singapore 266
Dearborn 259
Woodbridge 248
Ashburn 204
Fairfield 192
Jacksonville 187
Houston 178
New York 171
Princeton 149
Hong Kong 133
Boardman 106
Vienna 101
Nanjing 97
Shanghai 91
Seattle 81
Guangzhou 63
Beijing 60
Dong Ket 51
Santa Clara 42
Saint Petersburg 38
Cambridge 37
Altamura 36
Lawrence 32
Carate Brianza 30
Lachine 30
Rome 29
Daejeon 27
Nanchang 27
Shenyang 27
Falls Church 26
Fremont 26
Andover 25
Brussels 25
Pune 25
Ottawa 24
Helsinki 22
Jakarta 22
Sacramento 21
Kunming 20
Jinan 19
Shangdi 19
Toronto 18
London 16
Hangzhou 15
Nürnberg 15
Tianjin 15
Dallas 14
Kocaeli 14
San Diego 13
Sesto San Giovanni 13
Washington 13
Zhengzhou 13
Edmonton 12
Jiaxing 12
Los Angeles 12
Shinjuku 12
Changsha 11
Tokyo 11
Hebei 10
Hefei 10
Kiev 10
Kraków 10
Bergamo 9
Bolgare 9
Cagliari 9
Chicago 9
Genoa 9
Changchun 8
Grafing 8
Lappeenranta 8
Mountain View 8
Ningbo 8
Canazei 7
Mainz 7
Melzo 7
Munich 7
Norwalk 7
Piemonte 7
Seoul 7
Wuhan 7
Boston 6
Codroipo 6
Guidonia 6
Leawood 6
Melbourne 6
Monza 6
Phoenix 6
Segrate 6
Verona 6
Brno 5
Council Bluffs 5
Falkenstein 5
Florence 5
Fuzhou 5
Totale 8.021
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 368
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 353
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 317
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 313
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 288
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 282
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 279
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 270
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 265
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 231
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 220
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 206
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 198
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 192
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 192
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 188
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 180
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 179
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 175
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 174
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 169
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 168
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 165
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 164
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 158
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 153
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 152
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 149
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 143
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 143
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 137
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 134
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 130
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 128
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 127
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 125
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 125
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 125
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 123
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 123
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentation 122
MSCs effect on Dark Agouti rats affected by chronic EAE 122
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 121
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 119
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 118
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 117
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 117
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 115
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 115
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 113
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 113
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 110
Nose-to-brain delivery of polymeric nanoparticles 109
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 106
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 103
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 101
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 101
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 98
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 98
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 93
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 88
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 86
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 85
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 82
null 80
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 79
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 78
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 78
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 77
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 74
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 74
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 74
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 73
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 72
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 63
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 63
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 60
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 58
Blood NfL as a potential axonal damage marker in different CIPN rat models. 58
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 57
null 57
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 54
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 46
Histone deacetylases inhibitors: a new frontier for neuroprotection? 45
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 39
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 38
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 36
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 30
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 30
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 29
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 28
CIPN and its mechanism of development 27
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 22
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 20
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 15
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 9
Totale 11.906
Categoria #
all - tutte 37.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.420 0 0 111 96 136 241 265 109 138 163 135 26
2020/20212.080 77 58 265 196 180 224 223 220 175 146 123 193
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.289 217 531 299 238 208 324 57 105 138 40 63 69
2023/20241.731 59 65 61 119 197 362 307 98 101 47 57 258
2024/2025729 262 463 4 0 0 0 0 0 0 0 0 0
Totale 11.906